Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and Engagement
NCT ID: NCT04879927
Last Updated: 2023-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
125 participants
INTERVENTIONAL
2021-05-17
2023-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
NCT06908629
Feasibility of Health Coaching in Cancer Patients
NCT02556528
Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches
NCT01740219
A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer
NCT03721926
Healthy Directions After Lung Surgery Pilot
NCT02135211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The research study procedures include screening for social determinants of health (resource) needs and, depending on study group, resource matching.
* Participants will be randomized into one of two groups.
* Usual Care or Usual Care with customized resource matching.
It is expected that about 125 participants will take part in this research study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RESOURCE Matching
Participants randomized into the intervention arm will receive customized resource matching
Resource Matching
Resource staff involved in the customized resource matching arm of the intervention will include staff from DFCI Patient Services and DFCI Financial Counseling. Financial counseling will support patients with financial resource needs. DFCI Patient Services will provide assistance for all other patient Social Determinants of Health needs.
Usual Care
Participants randomized into the control group will receive a pre-existing pamphlet detailing DFCI resources
Usual Care
Patients randomized to the control group will receive a pre-existing pamphlet detailing DFCI resources.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Resource Matching
Resource staff involved in the customized resource matching arm of the intervention will include staff from DFCI Patient Services and DFCI Financial Counseling. Financial counseling will support patients with financial resource needs. DFCI Patient Services will provide assistance for all other patient Social Determinants of Health needs.
Usual Care
Patients randomized to the control group will receive a pre-existing pamphlet detailing DFCI resources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Group A
* BIPOC (Black, Latinx, Native American or Pacific Islander)
* LEP Spanish-speaking (As indicated by the EHR)
* Low SES (from zip code with median household income \<$32,000/year) OR
* Age 70+
* Group B
* Any one NPIQ response indicating SDoH need
* Health literacy/numeracy, Caregiving/relationships, OR Finances
Exclusion Criteria
\-- Patients not continuing care at Dana Farber Cancer Institute
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dana-Farber Cancer Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nadine McCleary, MD, MPH
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nadine J. McCleary, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-437
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.